LifeScan (the “Company”), a world leader in blood glucose monitoring, today announced its successful emergence from its Chapter 11 financial restructuring process following approval of its Plan of ...
Innovation requires collaboration. None of us can do it all ourselves. Companies that have embraced open innovation are looking outside their walls for new ideas. These companies are seeking out ...
A well-known brand of blood glucose meters, lancets, and test strips has tapped Sanvita Medical to develop sensors that integrate with its OneTouch Reveal diabetes management app. LifeScan, best-known ...
MALVERN, Pa., July 15, 2025--(BUSINESS WIRE)--LifeScan, Inc. ("LifeScan" or the "Company"), a world leader in blood glucose monitoring, today announced that it has entered into a Restructuring Support ...
LOS ANGELES, Oct. 02, 2018 (GLOBE NEWSWIRE) — Platinum Equity today announced that its acquisition of LifeScan from Johnson & Johnson (NYSE: JNJ) for approximately $2.1 billion has been completed, ...
Fitbit has partnered with diabetes tracking company LifeScan, offering users the chance to keep tabs on blood sugar trends within the Fitbit app. LifeScan offers cloud-based tracking of glucose levels ...
SAN FRANCISCO--(BUSINESS WIRE)--gA (Grupo Assa), a global leader in Digital Business Transformation, will be featured during Oracle® OpenWorld® 2018 as part of a case study outlining gA’s role in ...
Former Roche, Glutalor executive will help usher in a new era of innovation, growth, and expansion for the newly independent blood glucose monitoring company CHESTERBROOK, Pa., April 8, 2019 /CNW/ -- ...
In her new role, Ms. Rose will lead global marketing efforts and manage the innovation pipeline, commercialization of new digital health products and LifeSpan’s branding — including its OneTouch ...
Johnson & Johnson will sell its LifeScan diabetes unit to the private equity firm Platinum Equity for $2.1 billion, reports CNBC. 1. LifeScan, which produces blood glucose monitoring products, ...
Lifescan Inc., a maker of diabetes monitors, agreed to pay $45 million to diabetics in the United States to settle a class-action suit that claimed its products were dangerously defective. Lifescan, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results